| 发明名称 |
TARGETED SELECTION OF PATIENTS FOR TREATMENT WITH CORTISTATIN DERIVATIVES |
| 摘要 |
A method for the targeted selection and treatment of patients with a tumor or cancer, comprising (i) determining whether the patient has a RUNX1 pathway impairment; and if so (ii) administering an effective amount of a cortistatin or its pharmaceutically acceptable salt or oxide, optionally in a pharmaceutically acceptable composition. |
| 申请公布号 |
WO2016182904(A1) |
申请公布日期 |
2016.11.17 |
| 申请号 |
WO2016US31188 |
申请日期 |
2016.05.06 |
| 申请人 |
PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
发明人 |
SHAIR, Matthew, D.;PELISH, Henry, Efrem;NITULESCU, Ioana, Illinca |
| 分类号 |
A61P35/00;A61P35/02;A61P35/04;C07D493/08;C07D493/22 |
主分类号 |
A61P35/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
